Evidence map›Paper›PMID 24391647›Full record

ArticleFrontiers in immunology2013

Clonal exhaustion as a mechanism to protect against severe immunopathology and death from an overwhelming CD8 T cell response.

Markus Cornberg, Laurie L Kenney, Alex T Chen, Stephen N Waggoner, Sung-Kwon Kim, Hans P Dienes, Raymond M Welsh, Liisa K Selin

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian Adults.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Trial
  3. Review
  4. Article
  5. Review
  6. T cell adaptation in chronic infections and tumors.Cellular & molecular immunology · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. The magic of small-molecule drugs duringFrontiers in immunology · 2023
    Review
  19. Article
  20. CD8Nature reviews. Immunology · 2022
    Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Markus CornbergDepartment of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School , Hannover , Germany.
Laurie L KenneyProgram in Immunology and Virology, Department of Pathology, University of Massachusetts Medical School , Worcester, MA , USA.
Alex T ChenProgram in Immunology and Virology, Department of Pathology, University of Massachusetts Medical School , Worcester, MA , USA.
Stephen N WaggonerProgram in Immunology and Virology, Department of Pathology, University of Massachusetts Medical School , Worcester, MA , USA.
Sung-Kwon KimProgram in Immunology and Virology, Department of Pathology, University of Massachusetts Medical School , Worcester, MA , USA.
Hans P DienesClinical Institute of Pathology, Medical University of Vienna , Vienna , Austria.
Raymond M WelshProgram in Immunology and Virology, Department of Pathology, University of Massachusetts Medical School , Worcester, MA , USA.
Liisa K SelinProgram in Immunology and Virology, Department of Pathology, University of Massachusetts Medical School , Worcester, MA , USA.
Medical University of Vienna · ATMedizinische Hochschule Hannover · DE

Funding

Virology and Technology CoreP01AI046629 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GREINER, DALE LESLIE · 1999 to 2014
$19.1M
PILOT AND FEASIBILITY PROGRAMP30DK032520 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CZECH, MICHAEL P · 1986 to 2010
$14.6M
TRAINING IN IMMUNOLOGY (COMPETITIVE RENEWAL OF AI07439)T32AI007349 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STERN, LAWRENCE J. · 1989 to 2024
$4.5M
Immunity and Virus DiseaseR37AI017672 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WELSH, RAYMOND M · 2004 to 2013
$4.0M
IMMUNITY IN SYSTEMIC AND MUCOSAL VIRUS INFECTIONSR01AI046578 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SELIN, LIISA KAARINA · 2000 to 2009
$3.1M
Virus induced immunopathologyR01AI081675 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WELSH, RAYMOND M · 2009 to 2013
$2.0M
IMMUNITY AND VIRUS DISEASER01AI017672 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WELSH, RAYMOND M · 1985 to 2003
$1.4M
REGULATION OF NATURAL KILLER CELLSR01CA034461 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WELSH, RAYMOND M · 1985 to 2005
$1.3M
NCI NIH HHS R01 CA034461NIAID NIH HHS P01 AI046629NIAID NIH HHS R01 AI017672NIAID NIH HHS R01 AI046578NIAID NIH HHS R01 AI081675NIAID NIH HHS R37 AI017672NIAID NIH HHS T32 AI007349NIDDK NIH HHS P30 DK032520
6 · The paper itself

Abstract

The balance between protective immunity and immunopathology often determines the fate of the virus-infected host. How rapidly virus is cleared is a function of initial viral load, viral replication rate, and efficiency of the immune response. Here, we demonstrate, with three different inocula of lymphocytic choriomeningitis virus (LCMV), how the race between virus replication and T cell responses can result in different disease outcomes. A low dose of LCMV generated efficient CD8 T effector cells, which cleared the virus with minimal lung and liver pathology. A high dose of LCMV resulted in clonal exhaustion of T cell responses, viral persistence, and little immunopathology. An intermediate dose only partially exhausted the T cell responses and resulted in significant mortality, and the surviving mice developed viral persistence and massive immunopathology, including necrosis of the lungs and liver. This suggests that for non-cytopathic viruses like LCMV, hepatitis C virus, and hepatitis B virus, clonal exhaustion may be a protective mechanism preventing severe immunopathology and death.

Indexed as

CD8clonal exhaustionimmunopathologyLCMVliverlungT cells

Identifiers

PMID24391647
PMCPMC3869045
OpenAlexW2088719567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.